Literature DB >> 32040581

A Possible Mechanism behind Faster Clearance and Higher Peak Concentrations of Cardiac Troponin I Compared with Troponin T in Acute Myocardial Infarction.

Karin Starnberg1, Vincent Fridén1, Aida Muslimovic1, Sven-Erik Ricksten2, Susanne Nyström1, Niklas Forsgard1, Bertil Lindahl3,4, Kristina Vukusic1, Joakim Sandstedt1, Göran Dellgren5,6, Ola Hammarsten1.   

Abstract

BACKGROUND: Although cardiac troponin I (cTnI) and troponin T (cTnT) form a complex in the human myocardium and bind to thin filaments in the sarcomere, cTnI often reaches higher concentrations and returns to normal concentrations faster than cTnT in patients with acute myocardial infarction (MI).
METHODS: We compared the overall clearance of cTnT and cTnI in rats and in patients with heart failure and examined the release of cTnT and cTnI from damaged human cardiac tissue in vitro.
RESULTS: Ground rat heart tissue was injected into the quadriceps muscle in rats to simulate myocardial damage with a defined onset. cTnT and cTnI peaked at the same time after injection. cTnI returned to baseline concentrations after 54 h, compared with 168 h for cTnT. There was no difference in the rate of clearance of solubilized cTnT or cTnI after intravenous or intramuscular injection. Renal clearance of cTnT and cTnI was similar in 7 heart failure patients. cTnI was degraded and released faster and reached higher concentrations than cTnT when human cardiac tissue was incubated in 37°C plasma.
CONCLUSION: Once cTnI and cTnT are released to the circulation, there seems to be no difference in clearance. However, cTnI is degraded and released faster than cTnT from necrotic cardiac tissue. Faster degradation and release may be the main reason why cTnI reaches higher peak concentrations and returns to normal concentrations faster in patients with MI. © American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32040581     DOI: 10.1093/clinchem/hvz003

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  The Liver and Kidneys mediate clearance of cardiac troponin in the rat.

Authors:  Aida Muslimovic; Vincent Fridén; Olav Tenstad; Karin Starnberg; Susanne Nyström; Emelie Wesén; Elin K Esbjörner; Kristoffer Granholm; Bertil Lindahl; Ola Hammarsten
Journal:  Sci Rep       Date:  2020-04-22       Impact factor: 4.379

2.  The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients.

Authors:  Ola Hammarsten; Pontus Ljungqvist; Björn Redfors; Mathias Wernbom; Hannes Widing; Bertil Lindahl; Sabin Salahuddin; Ruwayda Sammantar; Sandeep Jha; Annica Ravn-Fischer; Magnus Brink; Magnus Gisslen
Journal:  Clin Chim Acta       Date:  2022-01-05       Impact factor: 3.786

3.  How is cardiac troponin released from cardiomyocytes?

Authors:  Ola Hammarsten; Mathias Wernbom; Nicholas L Mills; Christian Mueller
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2022-09-29

4.  Impedimetric cardiac biomarker determination in serum mediated by epoxy and hydroxyl of reduced graphene oxide on gold array microelectrodes.

Authors:  S Taniselass; Mohd Khairuddin Md Arshad; Subash C B Gopinath; M F M Fathil; C Ibau; Periasamy Anbu
Journal:  Mikrochim Acta       Date:  2021-07-15       Impact factor: 5.833

5.  Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population.

Authors:  Dorien M Kimenai; Anoop S V Shah; David A McAllister; Kuan Ken Lee; Athanasios Tsanas; Steven J R Meex; David J Porteous; Caroline Hayward; Archie Campbell; Naveed Sattar; Nicholas L Mills; Paul Welsh
Journal:  Clin Chem       Date:  2021-10-01       Impact factor: 12.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.